by Christie Knapper | Oct 6, 2021 | News
[Knoxville, TN] October 2021- Bill Malkes, Chief Executive Officer of NellOne Therapeutics, is the recipient of the 2021 Innov865 Impact Award. The Innov865 Impact Award, presented by Verizon, celebrates innovation and entrepreneurship in the community by recognizing...
by Christie Knapper | Sep 7, 2021 | News
WVLT’s Anne Brock recently sat down with NellOne Co-Founder and Chief Science Officer, Dr. Cymbeline “Bem” Culiat, on her research into healing after COVID-19 and her recently launched book, Designed to Heal, co-authored with physician and theologian...
by Christie Knapper | Aug 9, 2021 | News
[Knoxville, TN], August 9, 2021 – 490 BioTech and NellOne Therapeutics, Inc., two leaders in Tennessee’s thriving entrepreneurial community and members of its growing biotechnology cluster, announced today they are expanding their partnership to fight against acute...
by Christie Knapper | Jul 26, 2021 | News
A new model and resource for healing social injuries and divisions. [Knoxville, TN], July 26, 2021 – Dr. Cymbeline T. (Bem) Culiat, Co-Founder and Chief Science Officer for NellOne Therapeutics, Inc. (NellOne), along with pediatrician, and public health expert, Dr....
by Christie Knapper | May 4, 2021 | News
Small Business Innovation Research Program Provides Seed Funding for R&D [Knoxville, TN], April 26, 2021 – NellOne Therapeutics, Inc. (NellOne) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant for...
by Bandera Admin | Nov 10, 2020 | News
The novel coronavirus is no doubt top of mind for most people with the infection numbers rising rapidly on a daily, so an announcement last week from Oak Ridge National Laboratory (ORNL) that involves a local early stage biopharmaceutical...
